Effect of an inhibitor of squalene epoxidase, NB-598, on lipid metabolism in Hep G2 cells. 1992

Y Nagata, and M Horie, and Y Hidaka, and M Yonemoto, and M Hayashi, and H Watanabe, and F Ishida, and T Kamei
Central Research Laboratories, Banyu Pharmaceutical Co., Ltd., Tokyo, Japan.

NB-598, a potent inhibitor of squalene epoxidase, inhibited cholesterol synthesis from [14C]acetate and induced intracellular squalene accumulation in Hep G2 cells. NB-598 inhibited cholesterol synthesis from [14C]acetate, [3H]mevalonate, and [3H]squalene, but not from [3H]2,3-oxidosqualene in Hep G2 cells. It reduced cholesterol ester synthesis remarkably in the absence of exogenous cholesterol. This compound did not have any effect on the synthesis of ubiquinone and dolichol. When Hep G2 cells were prelabeled with micellar [3H]cholesterol, NB-598 did not affect the excretion of bile acid incorporated from [3H]cholesterol. However, NB-598 decreased the secretion of free and esterified cholesterol, triacylglycerol, and phospholipids, and increased the secretion of squalene. NB-598 is thought not only to inhibit cholesterol synthesis, but also to inhibit the secretion of lipids.

UI MeSH Term Description Entries
D010105 Oxygenases Oxidases that specifically introduce DIOXYGEN-derived oxygen atoms into a variety of organic molecules. Oxygenase
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002788 Cholesterol Esters Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis. Cholesterol Ester,Cholesteryl Ester,Cholesteryl Esters,Ester, Cholesterol,Ester, Cholesteryl,Esters, Cholesterol,Esters, Cholesteryl
D004286 Dolichols A class of polyprenols which contain approximately 20 isoprene residues. Although considered ISOPRENOIDS, they terminate with an alpha-saturated isoprenoid group at the hydroxy end of the molecule. 6,10,14,18,22,26,30,34,38,42,46,50,54,58,62,66,70,74,78-Octacontanonadecaen-1-ol, 3,7,11,15,19,23,27,31,35,39,43,47,51,55,59,63,67,71,75,79-eicosamethyl-,Dolichol,Eicosamethyl Octacontanonadecasen-1-ol,Eicosamethyl Octacontanonadecasen 1 ol,Octacontanonadecasen-1-ol, Eicosamethyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic
D001596 Benzylamines Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group. Phenylmethylamine,alpha-Aminotoluene,alpha Aminotoluene
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

Y Nagata, and M Horie, and Y Hidaka, and M Yonemoto, and M Hayashi, and H Watanabe, and F Ishida, and T Kamei
May 1992, Chemical & pharmaceutical bulletin,
Y Nagata, and M Horie, and Y Hidaka, and M Yonemoto, and M Hayashi, and H Watanabe, and F Ishida, and T Kamei
November 2001, European journal of pharmacology,
Y Nagata, and M Horie, and Y Hidaka, and M Yonemoto, and M Hayashi, and H Watanabe, and F Ishida, and T Kamei
August 1988, Biochimica et biophysica acta,
Y Nagata, and M Horie, and Y Hidaka, and M Yonemoto, and M Hayashi, and H Watanabe, and F Ishida, and T Kamei
November 1999, Journal of the American Society of Nephrology : JASN,
Y Nagata, and M Horie, and Y Hidaka, and M Yonemoto, and M Hayashi, and H Watanabe, and F Ishida, and T Kamei
January 2013, Acta biochimica Polonica,
Y Nagata, and M Horie, and Y Hidaka, and M Yonemoto, and M Hayashi, and H Watanabe, and F Ishida, and T Kamei
October 1995, Research communications in molecular pathology and pharmacology,
Y Nagata, and M Horie, and Y Hidaka, and M Yonemoto, and M Hayashi, and H Watanabe, and F Ishida, and T Kamei
December 1990, Biochemical Society transactions,
Y Nagata, and M Horie, and Y Hidaka, and M Yonemoto, and M Hayashi, and H Watanabe, and F Ishida, and T Kamei
December 2003, Biochemistry and cell biology = Biochimie et biologie cellulaire,
Y Nagata, and M Horie, and Y Hidaka, and M Yonemoto, and M Hayashi, and H Watanabe, and F Ishida, and T Kamei
November 1990, Journal of lipid research,
Y Nagata, and M Horie, and Y Hidaka, and M Yonemoto, and M Hayashi, and H Watanabe, and F Ishida, and T Kamei
January 1996, Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia,
Copied contents to your clipboard!